Affodel Tablet
Product Images NDC 79929-015

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Affodel (NDC 79929-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte. Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure 1)

Image Description (Figure 1)
Chemical structure of Norethindrone, a steroidal compound with several ring structures and functional groups including a hydroxyl group, methyl group, keto group, and a triple-bonded acetylene group.*
FDA Label Image

Image Description (Figure 2)

Image Description (Figure 2)
A line graph showing mean ± SD plasma concentrations of Norethindrone over time following oral administration of 0.35 mg. The x-axis represents time in hours up to 48, and the y-axis shows concentration in picograms per milliliter, illustrating a peak shortly after administration followed by a decline.*
FDA Label Image

Image Description (Figure 3)

Image Description (Figure 3)
Carton packaging label for Affodel (Norethindrone Tablets USP, 0.35 mg) by Naari Pte Limited. The label includes the product name, strength, and dosage form, with notice that it is Rx only and intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases. The carton holds 3 blister cards, each containing 28 tablets. Instructions, storage conditions, and distributor information are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.